Yoichi Naito

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Yoichi Naito

Jan 13, 2025, 10:23 | Science

The Randomized Noninferiority Phase III EMERALD Trial on HER2+ Locally Advanced/Metastatic Breast Cancer

A recent paper by Toshinari Yamashita et al. was published in the Journal of Clinical…

Jan 12, 2025, 08:51 | Blog

Eribulin + HP as first-line treatment of locally advanced/metastatic HER2+ breast cancer

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: "Trastuzumab-Pertuzumab Plus…

Sep 12, 2024, 09:36 | Blog

Heidi Ko: The importance of comprehensive genomic profiling in cancer of unknown primary

Heidi Ko, Medical Director, Medical Affairs, Labcorp Drug Development, shared a post on LinkedIn: "What…

All: 3 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023